COMP <GO>
GENC vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Gencor Industries Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: GENC 3
— TMO 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TMO
LAST: $17.36 (+1.22%) • MKT CAP: $254.5M
roic
6.20%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GENC VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GENC | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 27.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 6.20% | 9.30% | -3.10 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.5x | 30.4x | -14.90 | GENC | /valuation <GO> |
| Free Cash Flow Yield | 1.21% | 2.40% | -1.19 | TMO | /fcf-yield <GO> |
| Operating Margin | 12.10% | 17.40% | -5.30 | TMO | /operating-margins <GO> |
| Net Profit Margin | 13.60% | 15.10% | -1.50 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | — | 3.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 14.16 | 4.50 | +9.66 | GENC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.8 | 62.9 | -21.15 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.1x | 36.3x | -21.20 | GENC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $254.5M | $262.22B | -$261.96B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GENC REV | TMO REV | GENC GROSS % | TMO GROSS % | GENC FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $115.4M | $44.56B | 27.5% | — | $3.1M | $6.29B |
| FY 2024 | $113.2M | $42.88B | 27.7% | — | $9.3M | $7.27B |
| FY 2023 | $0 | $42.86B | — | — | $10.2M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GENC // BETA —
TMO // BETA 0.94